1. FDA papers Guidelines: “Manufacturing and Controls for INDs and NDAs”, Pharm. Tech. Japan, 1 835–850 (1985).
2. J. K. Haleblian, “Characterization of Habits and Crystalline Modification of Solids and Their Pharmaceutical Applications”, J. Pharm. Sci., 64, 1269–1288 (1975).
3. H. Ashizawa, “Thermal Analysis, X-ray Diffraction”, Ed. By H. Ashizawa, Sciences of Polymorphism and Crystallization of Pharmaceuticals, Maruzen Planet Co. Ltd. Tokyo, Japan, pp 58–101 (2002).
4. M. Otsuka, Y. Matsuda, “Polymorphism, Pharmaceutical Aspects”. Swarbrick, J.; Boylan, J. C. eds. Encyclopedia of Pharmaceutical Technology. Vol. 12. New York, Marcel Dekker, 305–326 (1995).
5. J. Bernstein, “Polymorphism in Molecular Crystals”; Clarendon Press: Oxford, Vol. 14 2002.